0001846253-23-000085.txt : 20230627 0001846253-23-000085.hdr.sgml : 20230627 20230627175621 ACCESSION NUMBER: 0001846253-23-000085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230623 FILED AS OF DATE: 20230627 DATE AS OF CHANGE: 20230627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cochran Jennifer R. CENTRAL INDEX KEY: 0001872349 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40720 FILM NUMBER: 231048691 MAIL ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INC STREET 2: 3911 SORRENTO VALLEY BOULEVARD, STE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OmniAb, Inc. CENTRAL INDEX KEY: 0001846253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 600 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-250-7800 MAIL ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 600 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Avista Public Acquisition Corp. II DATE OF NAME CHANGE: 20210212 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-06-23 0 0001846253 OmniAb, Inc. OABI 0001872349 Cochran Jennifer R. 5980 HORTON STREET, STE 600 EMERYVILLE CA 94608 1 0 0 0 0 Common Stock 91190 D Restricted Stock Units Common Stock 3792 3792 D Restricted Stock Units 2023-06-23 4 A 0 20000 0 A Common Stock 20000 23792 D Stock Option (right to buy) 4.81 2023-06-23 4 A 0 40000 0 A 2033-06-23 Common Stock 40000 40000 D The Reporting Person previously reported certain awards of Restricted Stock Units (RSUs) in Table I of Form 4, but has elected to report the RSUs in Table II going forward. As a result, the total reported in Column 5 of Table I has been updated to subtract 3,792 RSUs outstanding on June 23, 2023. Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in two equal annual installments, beginning July 12th, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (A) the date of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the date of grant. Each Stock Option shall vest and become exercisable in full on the earlier of (A) the date of the annual meeting of the Company's stockholders next following the grant date and (B) on the first anniversary of the date of grant. By: /s/ Charles S. Berkman For: Jennifer R. Cochran 2023-06-27